Compare

Heartbeam Inc./$BEAT

1D1W1M3M6MYTD1Y5YMAX

About Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Ticker
$BEAT
Sector
Health
Primary listing
NASDAQ
Employees
16
Headquarters
Santa Clara, United States
Website
www.heartbeam.com

Heartbeam Inc. Metrics

BasicAdvanced
$24M
-
-$0.50
-0.79
-

What the Analysts think about Heartbeam Inc.

Analyst ratings (Buy, Hold, Sell) for Heartbeam Inc. stock.
Analyst projections of the future price of Heartbeam Inc. stock.

Heartbeam Inc. Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Heartbeam Inc. News

AllArticlesVideos

HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time

Business Wire2 days ago

HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026

Business Wire1 week ago

HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System

Benzinga1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.